|
10/28/09
|
|
NIH-Funded Researchers Transform Embryonic Stem Cells Into Human Germ Cells
|
| Researchers funded in part by the National Institutes of Health have discovered how to transform human embryonic stem cells into germ cells, the embryonic cells that ultimately give rise to sperm and eggs. The advance will allow researchers to observe human germ cells—previously inaccessible—in laboratory dishes. |
|
|
07/20/09
|
|
NIH Issues Research Plan on Fragile X Syndrome and Associated Disorders
|
| The National Institutes of Health has developed a research plan to advance the understanding of fragile X syndrome and its associated conditions, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency. Fragile X syndrome causes intellectual and developmental disabilities and results from a mutation in a gene on the X chromosome. |
|
|
07/14/09
|
|
New Technique Could Sustain Cancer Patients' Fertility
|
| Researchers funded by the National Institutes of Health have completed a critical first step in the eventual development of a technique to retain fertility in women with cancer who require treatments that might otherwise make them unable to have children. |
|
|
06/19/09
|
|
Delay in Diagnosis of Menopause-like Condition in Young Women Linked to Low Bone Density
|
| Women and young girls who experience delays in diagnosing a premature, menopause-like condition face increased risk of low bone density, according to new research by scientists at the National Institutes of Health. A delay in diagnosing the condition, called primary ovarian insufficiency, may make women more susceptible to osteoporosis and fractures later in life, the researchers concluded. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/07/06
|
|
Hormonal Contraception Does Not Appear To Increase HIV Risk
|
| Using hormonal contraception does not appear to increase women's overall risk of infection with the AIDS virus, report the authors of a large study commissioned by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. |
|
|
|
|
|
|
08/23/04
|
|
Depo Provera Appears to Increase Risk for Chlamydial and Gonococcal Infections
|
| The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman's risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three fold when compared to women not using a hormonal contraceptive, according to a study jointly funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health and the U.S. Agency for International Development's Office of Population and Reproductive Health. |
|
|
|